Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Feuillard, M. Jacob, F. Valensi, M. Maynadie, R. Gressin, L. Chaperot, C. Arnoulet, F. Brignole-Baudouin, B. Drénou, E. Duchayne, A. Falkenrodt, R. Garand, Emanuelle Homolle, B. Husson, E. Kuhlein, G. Calvez, D. Sainty, M. Sotto, F. Trimoreau, M. Béné (2002)
Clinical and biologic features of CD4(+)CD56(+) malignancies.Blood, 99 5
F. Facchetti, Marta Cigognetti, S. Fisogni, G. Rossi, S. Lonardi, W. Vermi (2016)
Neoplasms derived from plasmacytoid dendritic cellsModern Pathology, 29
J. Vardiman, J. Thiele, D. Arber, R. Brunning, M. Borowitz, A. Porwit, N. Harris, M. Beau, E. Hellström-Lindberg, A. Tefferi, C. Bloomfield (2009)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.Blood, 114 5
F. Julia, T. Petrella, M. Beylot‐Barry, M. Bagot, Dan Lipsker, L. Machet, Pascal Joly, O. Dereure, M. Wetterwald, M. D’Incan, Florent Grange, J. Cornillon, G. Tertian, E. Maubec, P. Saiag, Stéphane Barete, I. Templier, François Aubin, Stéphane Dalle (2013)
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patientsBritish Journal of Dermatology, 169
T. Heinicke, H. Hütten, T. Kalinski, I. Franke, B. Bonnekoh, T. Fischer (2015)
Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation—a single center experienceAnnals of Hematology, 94
Jill Sullivan, D. Rizzieri (2016)
Treatment of blastic plasmacytoid dendritic cell neoplasm.Hematology. American Society of Hematology. Education Program, 2016 1
Ann Hematol (2017) 96:1769–1770 DOI 10.1007/s00277-017-3079-6 LETTER TO THE EDITOR Blastic plasmacytoid dendritic cell neoplasm: a pathological illustration of two clinical cases 1 2 3 4 2,5 Jessica C. Griffin & Nayef Aqel & Wenchee Siow & Marquita Camilleri & Robert Ayto Received: 10 June 2017 /Accepted: 23 July 2017 /Published online: 1 August 2017 Springer-Verlag GmbH Germany 2017 Dear Editor, and negative for CD34, CD117, MPO and CD33, compatible Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a with BPDCN (Fig. 1, d2). Infiltrative cells on lymph node rare aggressive disease characterised by clonal proliferation of biopsy were positive for CD4, CD56 and CD123. plasmacytoid dendritic cell precursors [1]. Defined as a mye- The patient commenced FLAG-IDA chemotherapy achiev- ing haematological and radiological complete remission post loid malignancy by the World Health Organisation [2], it has distinct morphological and immunophenotypic features. We cycle 1. He relapsed rapidly post a second cycle of FLAG- present two cases of BPDCN, with a visual illustration of the IDA in the short assessment period prior to reduced intensity pathological characteristics. allogenic bone marrow transplant. He failed salvage with A 69-year-old male presented with 2 months history of high-dose methotrexate and died from sepsis
Annals of Hematology – Springer Journals
Published: Aug 1, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.